Traditional clinical trial recruitment processes present multiple challenges, from underperforming sites to unresponsive patients.

Up to 80% of studies experience recruitment-related delays, while 85% fail to maintain a sample population of enough patients.

Given the increasing difficulty of recruiting patients, biopharma companies, contract research organizations (CROs), and other trial sponsors and organizers must develop new strategies to attract and engage participants.

One of the best examples of these strategies is direct-to-patient clinical trial recruitment. The direct-to-patient (DtP) model allows researchers to find and engage potential participants more easily through targeted campaigns, such as digital advertising.

DtP recruitment strategies also help eliminate some complexities of managing clinical studies at a central site, such as patients’ logistical burdens. This strategy uses technology to connect all stakeholders, collect electronic medical records (EMR), screen and enroll potential participants, and centralize operations for effective management. DtP is designed to improve patient recruitment strategy and create more efficient clinical trial opportunities for participants and researchers alike.

Learn more about the DtP model below and how sponsors and organizers can use it to improve patient recruitment and meet their goals.

Understanding Direct-to-Patient Clinical Trial Recruitment

The direct-to-patient model promotes awareness of and enrollment in numerous studies and treatments by leveraging partnerships with advocacy groups and other organizations. It directly reaches patients through social media, email, and search engine results. This method differs from traditional trial recruitment, which generally requires healthcare providers, patient advocacy groups, and patient data organizations who refer potentially eligible patients to trials.

Traditional recruitment contends with major hurdles that inherently restrict a trial’s likelihood of success, including:

• Healthcare providers maintaining awareness of new and ongoing trials
• Healthcare providers identifying and informing potentially eligible patients
• Patients seeking out trial screening and enrollment at a physical site, which introduces even more logistical hurdles (e.g., travel time, travel costs, and getting time off from work)

There are simply too many challenges for traditional methods to be reliable.
Conversely, direct-to-patient (DtP) recruitment can easily reach, educate, and enroll more qualified patients through targeted engagements.

Crucially, DtP places patients at the center of the recruitment process, reaching out to them (e.g., through their preferred social media platforms and search engines) rather than contacting providers and hoping they pass along the information.

This method considerably expands and simplifies patient recruitment by directly engaging more potential participants and facilitating enrollment steps through an online portal. Awareness, information, and signup all accommodate patients’ needs and convenience.

This approach continues to become an increasingly important component of decentralized clinical trials (DCTs), which use technology and remote data collection to conduct research outside traditional clinical settings. DCTs are shaping the future of clinical research and can potentially improve broader patient outcomes through accessibility, retention, and trial diversity. However, these benefits first require reaching the right participants.

Benefits of Direct-to-Patient Recruitment

Patient recruitment is the most challenging and expensive part of any clinical trial, constituting 32% of the total budget. Direct-to-patient (DtP) strategies seek a scalable and cost-effective way to recruit patients and reduce costs.

DtP benefits include:

• Patient diversity: By reaching broader populations through digital clinical trial advertising, DtP better enables the recruitment of trial participants from isolated or underrepresented populations and across countries or continents, allowing studies to enroll more diverse individuals.
• Patient-centric: This method makes participation more manageable for patients, removing awareness, information, and logistical barriers like travel and time commitments. This boosts patient engagement and empowerment (particularly for those with chronic conditions who struggle to make site visits) as potential participants feel fully knowledgeable and don’t need to make extensive changes to participate.
• Better patient retention: Clinical studies face a drop-out rate of 25-30%, primarily due to poor engagement and inconvenience. By eliminating the common barriers prohibiting participation, DtP inherently improves retention and adherence.
• Cost-effective: Running a study site can be costly for CROs, sponsors, and patients. DtP accelerates trial timeliness, reduces logistical burdens, streamlines processes, and minimizes clinic visits, cutting the overall cost of the study.
• Highly scalable: DtP trial recruitment focuses on remote operations, meaning it overcomes the limitations of in-person/on-site trials. Biopharma companies can quickly scale their operations depending on their needs and drug development goals.

Direct-to-patient helps eliminate obstacles that add cost, time, and uncertainty to patient recruitment efforts. It even proved an effective strategy during the COVID pandemic, when in-person operations were impossible.

For instance, Duke Clinical Research Institute (DCRI) researchers used the DtP approach to recruit mothers and infants for a COVID-19 study. It enabled the team to transition from an in-person model to an electronic-based, site-free, remote study, employing technological devices and electronic data capture systems to simplify the experience.

Challenges in Direct-to-Patient Recruitment

Despite the benefits of direct-to-patient recruitment, this model presents unique challenges that can impact a trial’s timelines and flexibility, including:

• Regulatory requirement hurdles and privacy concerns: Regulations, such as those set by the US Food and Drug Administration (FDA), International Review Boards (IRB), and the Health Insurance Portability and Accountability Act (HIPAA), remain in effect regardless of recruiting methods. Additional requirements will also vary from one state or country to another (e.g., general consumer data privacy laws), which may make it challenging to launch multi-region clinical trials. CROs must manage this compliance or find a specialized recruiting partner to properly handle marketing and communication.
• Technology barriers: Some patients may lack access to or familiarity with the digital tools used to complete screening and enrollment. Experienced support services must be readily available through an internal team or an external partner to assist patients as needed.
• Connecting with patients: When patients learn about trials via digital advertising, and then complete initial screening and enrollment online, there remains a risk of the interactions becoming too impersonal or disconnected. All communication means and content must aim to build trust and relieve any concerns that might develop for patients already facing mental health challenges, stress, and other difficulties due to their health conditions.

To address the biggest challenges, CROs and biopharma companies must focus on effective trial design and attention to communication and collaboration. They must establish clear delivery protocols, ensure materials and contact methods comply with requirements, and consider any local regulatory frameworks early in the planning stage.

Working with the right patient recruitment services partner will also help navigate the complexities of digital technologies and take advantage of direct recruitment. AutoCruitment offers compliant direct-to-patient digital recruitment through enhanced digital advertising methods and advanced algorithms to identify and engage qualified participants.

How Direct-to-Patient Clinical Trials Impact Patient Recruitment

Patients prefer direct-to-patient trials to traditional clinical trials due to their convenience and flexibility. They incorporate digital health technologies (DHTs) that simplify the whole experience for participants. Patients can use a provided portal or other tools to capture healthcare information and get started.

Direct-to-patient (DtP) trials use social marketing strategies, digital platforms, and print marketing to recruit diverse patients from isolated, hard-to-reach areas. For example, one trial used DtP strategies to recruit patients with cardiovascular diseases for a study on oral anticoagulant prophylaxis. The study attracted over 600 patients across US demographics, improving racial, gender, and older adult representation.

This marketing method can also recruit many trial participants. For instance, the Heartline Study leveraged DtP recruitment for a mobile app-based heart health program targeting patients 65 and older for atrial fibrillation. The model yielded around 300,000 app installations, with over 34,000 patients enrolling in the program.

With an experienced partner, the right strategy, and effective trial design, DtP recruitment tactics better engage and enroll diverse patients for clinical trials and drug development. Pharmaceutical companies should embrace this model to run patient-centric trials and deliver more value for sponsors.

Leverage Direct-to-Patient Recruitment with AutoCruitment

Patient recruitment is the biggest challenge in clinical trials, directly impacting the study’s duration and the quality of results. The problem becomes even more pronounced in studies requiring patient referrals, site visits, and travel, deterring interested patients who may lack the time or resources or live far from a physical study site.

Direct-to-patient (DtP) clinical trial recruitment introduces a novel approach that addresses different hurdles when attracting study participants. DtP allows patients to discover, learn about, and enroll in clinical trials from the comfort of their home or preferred digital channels, saving them time, costs, uncertainty, stress, and other inconveniences common to traditional processes.

At AutoCruitment, we help address patient recruitment and enrollment challenges through the use of evolved direct-to-patient approaches. We prioritize patient preferences and needs while leveraging digital strategies and technology to enhance screening, engagement, seamless data collection, and practical qualification.

Contact us today to learn how our direct-to-patient digital recruitment services can help you recruit motivated and eligible patients (and keep them engaged) for your next clinical trial.